Dallas, TX - The fibrate hypolipemic fenofibrate failed to significantly reduce the primary end point (CHD death or nonfatal MI) vs placebo in diabetic patients in the Fenofibrate Intervention and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback